BLUEJAY DIAGNOSTICS INC (BJDX) Stock Price, Quote, News and Overview
NASDAQ:BJDX - Nasdaq - US0956335097 - Common Stock - Currency: USD
BJDX Quote, Performance and Key Statistics
NASDAQ:BJDX (3/7/2025, 8:07:43 PM)
4.19
-0.07 (-1.64%)
The current stock price of BJDX is 4.19 USD. In the past month the price increased by 18.7%. In the past year, price decreased by -98.84%.
BJDX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 29.37 | 237.84B | ||
| ISRG | INTUITIVE SURGICAL INC | 70.7 | 184.84B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.49 | 146.29B | ||
| SYK | STRYKER CORP | 31.12 | 144.73B | ||
| MDT | MEDTRONIC PLC | 17.7 | 121.20B | ||
| BDX | BECTON DICKINSON AND CO | 16.5 | 65.91B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.84 | 41.35B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.28 | 39.59B | ||
| IDXX | IDEXX LABORATORIES INC | 38.23 | 34.98B | ||
| RMD | RESMED INC | 26.29 | 34.14B | ||
| DXCM | DEXCOM INC | 47.18 | 30.42B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 18.25 | 25.91B |
Related stock screener links
About BJDX
Company Profile
Bluejay Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Acton, Massachusetts and currently employs 10 full-time employees. The company went IPO on 2021-11-10. Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a rapid, near-patient testing system for triage and monitoring of disease progression. Its product candidate, an IL-6 Test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform is a combination of its intellectual property (IP) and exclusively licensed and patented IP that consists of a mobile device and single-use test cartridges. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices market, including sepsis, cardio-metabolic diseases, cancer and other diseases that require rapid tests. Symphony targets critical care markets where physicians must quickly determine patient acuity to identify optimal treatment regimens.
Company Info
BLUEJAY DIAGNOSTICS INC
360 Massachusetts Avenue, Suite 203
Acton MASSACHUSETTS US
Employees: 10
Company Website: https://bluejaydx.com/
Investor Relations: https://ir.bluejaydx.com/
Phone: 19786310152
BLUEJAY DIAGNOSTICS INC / BJDX FAQ
What is the stock price of BLUEJAY DIAGNOSTICS INC today?
The current stock price of BJDX is 4.19 USD. The price decreased by -1.64% in the last trading session.
What is the ticker symbol for BLUEJAY DIAGNOSTICS INC stock?
The exchange symbol of BLUEJAY DIAGNOSTICS INC is BJDX and it is listed on the Nasdaq exchange.
On which exchange is BJDX stock listed?
BJDX stock is listed on the Nasdaq exchange.
What is BLUEJAY DIAGNOSTICS INC worth?
BLUEJAY DIAGNOSTICS INC (BJDX) has a market capitalization of 2.30M USD. This makes BJDX a Nano Cap stock.
How many employees does BLUEJAY DIAGNOSTICS INC have?
BLUEJAY DIAGNOSTICS INC (BJDX) currently has 10 employees.
What are the support and resistance levels for BLUEJAY DIAGNOSTICS INC (BJDX) stock?
BLUEJAY DIAGNOSTICS INC (BJDX) has a support level at 3.68 and a resistance level at 4.21. Check the full technical report for a detailed analysis of BJDX support and resistance levels.
Should I buy BLUEJAY DIAGNOSTICS INC (BJDX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BJDX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BJDX, evaluating the profitability, health, valuation and growth aspects
- BLUEJAY DIAGNOSTICS INC (BJDX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BLUEJAY DIAGNOSTICS INC (BJDX) Sales and EPS estimates to see what analysts future expectations are.
- BLUEJAY DIAGNOSTICS INC (BJDX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BLUEJAY DIAGNOSTICS INC (BJDX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BLUEJAY DIAGNOSTICS INC (BJDX) Stock Chart to make your own analysis
- BLUEJAY DIAGNOSTICS INC (BJDX) Latest news and press-releases to stay up to date.
Does BLUEJAY DIAGNOSTICS INC (BJDX) stock pay dividends?
BJDX does not pay a dividend.
What is the Price/Earnings (PE) ratio of BLUEJAY DIAGNOSTICS INC (BJDX)?
BLUEJAY DIAGNOSTICS INC (BJDX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-72.72).
What is the Short Interest ratio of BLUEJAY DIAGNOSTICS INC (BJDX) stock?
The outstanding short interest for BLUEJAY DIAGNOSTICS INC (BJDX) is 2.75% of its float. Check the ownership tab for more information on the BJDX short interest.
BJDX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BJDX. When comparing the yearly performance of all stocks, BJDX is a bad performer in the overall market: 94.35% of all stocks are doing better.
BJDX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BJDX. While BJDX seems to be doing ok healthwise, there are quite some concerns on its profitability.
BJDX Financial Highlights
Over the last trailing twelve months BJDX reported a non-GAAP Earnings per Share(EPS) of -72.72. The EPS increased by 3.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.62% | ||
| ROE | -108.86% | ||
| Debt/Equity | 0.02 |
BJDX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to BJDX. The Buy consensus is the average rating of analysts ratings from 6 analysts.